Close
CDMO Safety Testing 2026
Novotech

DEA’s 10th National Drug Take-Back Day Set For September 26th

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Cell and Gene Therapy Manufacturing Entering GMP Era

The rapid and profound maturation of the global biopharmaceutical sector is being clearly marked by cell and gene therapy manufacturing entering GMP era. This critical transition involves the large-scale implementation of rigorous and uncompromising Good Manufacturing Practice standards to ensure that these complex, "living" treatments are produced with a level of consistent quality and safety that meets international requirements. By adopting highly automated systems, closed-loop processing, and robust, data-driven regulatory frameworks, the industry is successfully overcoming the historical hurdles of scalability and biological variability, paving the way for these advanced therapies to reach much broader patient populations across the globe.

How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC

Color consistency is critical in pharmaceutical quality control (QC)....

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...
- Advertisement -

DEA began hosting National Prescription Drug Take-Back events in 2010. At the previous nine Take-Back Day events, 4,823,251 pounds (2,411 tons) of unwanted, unneeded or expired medications were surrendered for safe and proper disposal. The disposal service is free and anonymous for consumers, with no questions asked. Collection sites and information for every local community can be found by going to www.dea.gov. This site will be continuously updated with new take-back locations.

Prescription medications play an important role in the health of millions of Americans. However, expired medications or unused drugs often stay in the back of cabinets for months or even years. These expired drugs can pose significant health hazards to toddlers, teens and even family pets who may inadvertently consume medications. Some medications are so potent that even one dose could be fatal if accidentally ingested. Throwing away certain medications in trash cans or flushing them down the toilet can be a safety and health hazard, too.

There are other important safety issues, as well: misuse of prescription drugs is second only to marijuana use as the nation’s most commonly used illicit drug. A U.S. government report shows that more than 70 percent of people who first misuse prescription drugs get them from their friends, relatives or simply take them without asking. According to the 2013 National Survey on Drug Use and Health (NSDUH), 4.2 percent of Americans aged 12 or older engaged in nonmedical use of prescription pain relievers in the past year. Nonmedical use is defined as the use of prescription-type drugs not prescribed for the user by a physician or used only for the experience or feeling they cause.

While the number of Americans who currently abuse prescription drugs dropped from 6.8 million in 2012 to 6.5 million in 2013, that is still more than double the number of those using illicit drugs of abuse like heroin, cocaine, and LSD combined. According to the 2013 Monitoring the Future Survey, over 28 percent of 12th graders had abused prescription medications in the past 12 months. These statistics magnify the need for proper disposal of unused or expired prescription medications.

The DEA’s “Take-Back” initiative is one of four strategies under the Secure and Responsible Drug Disposal Act of 2010 to reduce prescription drug abuse and diversion in the United States. Additional strategies include education of health care providers, patients, parents and youth; establishing prescription drug monitoring programs in all 50 states; and increased enforcement to address illicit methods of prescription drug diversion.

Consumers may also continue to utilize the guidelines for the disposal of controlled substances listed by the Food and Drug Administration if they are not able to attend the scheduled Take-Back Day.

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Cell and Gene Therapy Manufacturing Entering GMP Era

The rapid and profound maturation of the global biopharmaceutical sector is being clearly marked by cell and gene therapy manufacturing entering GMP era. This critical transition involves the large-scale implementation of rigorous and uncompromising Good Manufacturing Practice standards to ensure that these complex, "living" treatments are produced with a level of consistent quality and safety that meets international requirements. By adopting highly automated systems, closed-loop processing, and robust, data-driven regulatory frameworks, the industry is successfully overcoming the historical hurdles of scalability and biological variability, paving the way for these advanced therapies to reach much broader patient populations across the globe.

How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC

Color consistency is critical in pharmaceutical quality control (QC)....

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »